Sources

5 Total Sources

Parabilis Debuts With $670 Million Nasdaq IPO as Biotech Window Reopens for De-Risked Pipelines

Left100%
BioSpace36d ago
Parabilis Debuts on Nasdaq with Record $670M IPO, Surpassing Kailera Therapeutics
Bloomberg37d ago
Parabilis Medicines Shares Jump 67% After $745 Million Upsized US IPO
scanx.trade37d ago
Parabilis Medicines prices $670 million upsized IPO
Pharmaceutical Executive36d ago
Parabilis Medicines Achieves Record $3.7 Billion Market Cap on First Trading Day After $670 Million IPO
Binance37d ago
STOCKS | Parabilis Medicines Jumps 67% in Debut After Nearly $745 Million Upsized IPO | Binance News on Binance Square